CD44 gene polymorphisms and environmental factors on oral cancer susceptibility in Taiwan

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Chou, Ying Erh ^a   Hsieh, Ming Ju ^a,b   Hsin, Chung Han ^a,c   Chiang, Whei Ling ^a   Lai, Yi Cheng ^a   Lee, Yu Hsien ^a,c   Huang, Shu Ching ^a,c   Yang, Shun Fa ^a,c   Lin, Chiao Wen ^a,c  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; CD44 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ADULT; ARTICLE; BETEL NUT; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CD44 GENE; CLINICAL FEATURE; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING HABIT; SUBSTANCE USE; TAIWAN; AGED; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; ANTIGENS, CD44; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; POLYMORPHISM, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; TAIWAN;

EID: 84899455921     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093692     Document Type: Article

References (50)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2009) Cancer statistics, 2009. CA Cancer J Clin 59: 225-249.
2. Chien MH, Liu YF, Hsin CH, Lin CH, Shih CH, et al. (2013) Impact of VEGFC gene polymorphisms and environmental factors on oral cancer susceptibility in Taiwan. PLoS One 8: e60283.
3. Haddad RI, Shin DM (2008) Recent Advances in Head and Neck Cancer. N Engl J Med 359: 1143-1154.
4. Rogers SN, Brown JS, Woolgar JA, Lowe D, Magennis P, et al. (2009) Survival following primary surgery for oral cancer. Oral Oncol 45: 201-211.
5. Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM, et al. (1995) Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med 24: 450-453.
6. Lu CT, Yen YY, Ho CS, Ko YC, Tsai CC, et al. (1996) A case-control study of oral cancer in Changhua County, Taiwan. J Oral Pathol Med 25: 245-248.
7. Yen TT, Lin WD, Wang CP, Wang CC, Liu SA (2008) The association of smoking, alcoholic consumption, betel quid chewing and oral cavity cancer: a cohort study. Eur Arch Otorhinolaryngol 265: 1403-1407.
8. Goodison S, Urquidi V, Tarin D (1999) CD44 cell adhesion molecules. Mol Pathol 52: 189-196. (Pubitemid 29369203)
9. Marhaba R, Zöller M (2004) CD44 in cancer progression: adhesion, migration and growth regulation. J Mol Histol 35: 211-231. (Pubitemid 40585308)
10. Hill A, McFarlane S, Johnston PG, Waugh DJ (2006) The emerging role of CD44 in regulating skeletal micrometastasis. Cancer Lett 237: 1-9.
11. Marhaba R, Klingbeil P, Nuebel T, Nazarenko I, Buechler MW, et al. (2008) CD44 and EpCAM: cancer-initiating cell markers. Curr Mol Med 8: 784-804.
12. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, et al. (2007) Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 104: 973-978. (Pubitemid 46154721)
13. Wang SJ, Bourguignon LY (2011) Role of hyaluronan-mediated CD44 signaling in head and neck squamous cell carcinoma progression and chemoresistance. Am J Pathol 178: 956-963.
14. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, et al. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715. (Pubitemid 351636299)
15. Joshua B, Kaplan MJ, Doweck I, Pai R, Weissman IL, et al. (2012) Frequency of cells expressing CD44, a Head and Neck cancer stem cell marker: correlation with tumor aggressiveness. Head Neck 34: 42-49.
16. deJong MC, Pramana J, van der Wal JE, Lacko M, Peutz-Kootstra CJ, et al. (2010) CD44 expression predicts local recurrence after radiotherapy in larynx cancer. Clin Cancer Res 16: 5329-5338.
17. Judd NP, Winkler AE, Murillo-Sauca O, Brotman JJ, Law JH, et al. (2012) ERK1/2 regulation of CD44 modulates oral cancer aggressiveness. Cancer Res 72: 365-374.
18. Sauna ZE, Kimchi-Sarfaty C, Ambudkar SV, Gottesman MM (2007) Silent polymorphisms speak: how they affect pharmacogenomics and the treatment of cancer. Cancer Res 67: 9609-9612. (Pubitemid 47621204)
19. Morley M, Molony CM, Weber TM, Devlin JL, Ewens KG, et al. (2004) Genetic analysis of genome-wide variation in human gene expression. Nature 430: 743-747. (Pubitemid 39071339)
20. Vazquez A, Grochola LF, Bond EE, Levine AJ, Taubert H, et al. (2010) Chemosensitivity profiles identify polymorphisms in the p53 network genes 14-3-3tau and CD44 that affect sarcoma incidence and survival. Cancer Res 70: 172-180.
21. Gerger A, Zhang W, Yang D, Bohanes P, Ning Y, et al. (2011) Common cancer stem cell gene variants predict colon cancer recurrence. Clin Cancer Res 17: 6934-6943.
22. Zhou J, Nagarkatti PS, Zhong Y, Creek K, Zhang J, et al. (2010) Unique SNP in CD44 intron 1 and its role in breast cancer development. Anticancer Res 30: 1263-1272.
23. Jiang L, Deng J, Zhu X, Zheng J, You Y, et al. (2012) CD44 rs13347 C>T polymorphism predicts breast cancer risk and prognosis in Chinese populations. Breast Cancer Res 14: R105.
24. Winder T, Ning Y, Yang D, Zhang W, Power DG, et al. (2011) Germline polymorphisms in genes involved in the CD44 signaling pathway are associated with clinical outcome in localized gastric adenocarcinoma. Int J Cancer 129: 1096-1104.
25. Lu DY, Yeh WL, Huang SM, Tang CH, Lin HY, Chou SJ (2012) Osteopontin increases heme oxygenase-1 expression and subsequently induces cell migration and invasion in glioma cells. Neuro Oncol 14: 1367-1378.
26. Tsai CF, Yeh WL, Huang SM, Tan TW, Lu DY (2012) Wogonin induces reactive oxygen species production and cell apoptosis in human glioma cancer cells. Int J Mol Sci 13: 9877-9892.
27. Huang SM, Cheung CW, Chang CS, Tang CH, Liu JF, et al. (2011) Phloroglucinol derivative MCPP induces cell apoptosis in human colon cancer. J Cell Biochem 2011; 112: 643-652.
28. Lu CT, Lan SJ, Hsieh CC, Yang MJ, Ko YC, et al. (1993) Prevalence and characteristics of areca nut chewers among junior high school students in Changhua county, Taiwan. Community Dent Oral Epidemiol 21: 370-373.
29. Kokko LL, Hurme S, Maula SM, Alanen K, Grénman R, et al. (2011) Significance of site-specific prognosis of cancer stem cell marker CD44 in head and neck squamous-cell carcinoma. Oral Oncol 47: 510-516.
30. Yang YH, Chen CH, Chang JS, Lin CC, Cheng TC, et al. (2005) Incidence rates of oral cancer and oral pre-cancerous lesions in a 6-year follow-up study of a Taiwanese aboriginal community. J Oral Pathol Med 34: 596-601. (Pubitemid 41512945)
31. Kuo MY, Cheng SJ, Chen HM, Kok SH, Hahn LJ, et al. (1998) Expression of CD44s, CD44v5, CD44v6 and CD44v7-8 in betel quid chewing-associated oral premalignant lesions and squamous cell carcinomas in Taiwan. J Oral Pathol Med 27: 428-33. (Pubitemid 28490131)
32. Bourguignon LY, Zhu H, Zhou B, Diedrich F, Singleton PA, et al. (2001) Hyaluronan promotes CD44v3-Vav2 interaction with Grb2-p185(HER2) and induces Rac1 and Ras signaling during ovarian tumor cell migration and growth. J Biol Chem 276: 48679-48692.
33. Maula SM, Luukkaa M, Grénman R, Jackson D, Jalkanen S, et al. (2003) Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region. Cancer Res 63: 1920-6. (Pubitemid 36460859)
34. Situ D, Long H, Lin P, Zhu Z, Wang J, et al. (2010) Expression and prognostic relevance of CD44v6 in stage I non-small cell lung carcinoma. J Cancer Res Clin Oncol 136: 1213-1219.
35. González-Moles MA, Gil-Montoya JA, Ruiz-Avila I, Esteban F, Delgado-Rodriguez M, et al. (2007) Prognostic significance of p21WAF1/CIP1, p16INK4a and CD44s in tongue cancer. Oncol Rep 18: 389-396.
36. Stoll C, Baretton G, Soost F, Terpe HJ, Domide P, et al. (1999) Prognostic importance of the expression of CD44 splice variants in oral squamous cell carcinomas. Oral Oncol 35: 484-489. (Pubitemid 29386784)
37. Chen YW, Chen KH, Huang PI, Chen YC, Chiou GY, et al. (2011) Cucurbitacin I suppressed stem-like property and enhanced radiationinduced apoptosis in head and neck squamous carcinoma-derived CD44(+)ALDH1(+) cells. Mol Cancer Ther 9: 2879-2892.
38. Okamoto I, Tsuiki H, Kenyon LC, Godwin AK, Emlet DR, et al. (2002) Proteolytic cleavage of the CD44 adhesion molecule in multiple human tumors. Am J Pathol 160: 441-447. (Pubitemid 34160321)
39. Shastry BS (2009) SNPs: impact on gene function and phenotype. Methods Mol Biol 578: 3-22.
40. Costea DE, Tsinkalovsky O, Vintermyr OK, Johannessen AC, Mackenzie IC. (2006) Cancer stem cells - new and potentially important targets for the therapy of oral squamous cell carcinoma. Oral Dis 12: 443-454. (Pubitemid 44252536)
41. Zhang Z, Filho MS, Nör JE (2012) The biology of head and neck cancer stem cells. Oral Oncol 48: 1-9.
42. Facompre N, Nakagawa H, Herlyn M, Basu D (2012) Stem-like cells and therapy resistance in squamous cell carcinomas. Adv Pharmacol 65: 235-265.
43. Mǎrgǎritescu C, Pirici D, Simionescu C, Stepan A (2011) The utility of CD44, CD117 and CD133 in identification of cancer stem cells (CSC) in oral squamous cell carcinomas (OSCC). Rom J Morphol Embryol 52: 985-993.
44. Hirschmann-Jax C, Foster AE, Wulf GG, Nuchtern JG, Jax TW, et al. (2004) A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci U S A 101: 14228-14233. (Pubitemid 39305058)
45. Okamoto A, Chikamatsu K, Sakakura K, Hatsushika K, Takahashi G, et al. (2009) Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck. Oral Oncol 45: 633-639.
46. Ponta H, Sherman L, Herrlich PA (2003) CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 4: 33-45. (Pubitemid 36077255)
47. Weg-Remers S, Ponta H, Herrlich P, König H (2001) Regulation of alternative pre-mRNA splicing by the ERK MAP-kinase pathway. EMBO J 20: 4194-4203. (Pubitemid 32751835)
48. Hofmann M, Rudy W, Günthert U, Zimmer SG, Zawadzki V, et al. (1993) A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells. Cancer Res 53: 1516-1521. (Pubitemid 23113222)
49. Strobeck MW, DeCristofaro MF, Banine F, Weissman BE, Sherman LS, et al. (2001) The BRG-1 subunit of the SWI/SNF complex regulates CD44 expression. J Biol Chem 276: 9273-9278.
50. Reisman DN, Strobeck MW, Betz BL, Sciariotta J, Funkhouser W Jr, et al. (2002) Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs CD44 expression. Oncogene 21: 1196-1207. (Pubitemid 34185236)